EGFR and non-small cell lung carcinoma: Earlier work suggested an association between patient outcomes and the combination of high chromosome 7 copy number (CEN7; a surrogate for EGFR copy number gain due to polysomy) and PTEN expression in advanced NSCLC patients treated with gefitinib (Buckingham et al, 2007).